Program Information

The program is designed to support innovative scientific research related to Liver Disease. This may include, but is not limited to, research focused on:

• Chronic viral hepatitis (B, C, D)

• Hepatocellular carcinoma (HCC)

• End-stage liver disease and its complications

• Non-viral chronic liver diseases

• Health economics outcomes research relating to liver disease

Awards granted under the program may not be duplicative of funding from institutional or hospital, other governmental, non-governmental, or industry sources. Applicants seeking an award for research projects that are currently receiving or may receive partial funding from other sources are required to submit appropriate evidence, including budget information related to the other sources, to demonstrate that there is no direct overlap or duplication in funding.

Proposals utilizing Gilead product(s) are not eligible for funding through the Research Scholars Program. Proposals involving Gilead product(s) should be submitted for review under the Investigator-Sponsored Research Grant Program through the ISR online portal.

Proposals are reviewed by an independent Scientific Review Committee (no Commercial involvement in review and selection, i.e., Marketing, Sales, and Commercial Strategy), and are reviewed based upon the criteria outlined on this website.

While the Research Scholars Program is intended to support independent research by emerging investigators that is unrelated to Gilead’s strategy, all research projects selected by the Scientific Review Committee will need to be approved by an internal validation committee that may, in rare circumstances, be unable to support research if it directly compromises the existing Gilead Virology portfolio of evidence.

October 2022, IHQ-UNB-2842